IP Library Granted Patent US 7,390,800
Granted Patent B2
US 7,390,800 · App. 10/550,301 · Granted Jun 24, 2008

Adenosine deaminase inhibitor and novel

Assignee: FCB-Pharmicell Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,390,800
App. No.
10/550,301
Granted
Jun 24, 2008
Kind
B2
Abstract

The present invention relates to an adenosine deaminase inhibitor and a novel Bacillus sp. strain which produces it. Particularly, the present 5 invention relates to the adenosine deaminase inhibitor, and the novel Bacillus sp. IADA-7 producing the above adenosine deaminase inhibitor. The adenosine deaminase inhibitor of the present Invention shows superior antibacterial and anticancer activities to the previously reported adenosine deaminase inhibitors.

Claims (9)

1. A compound of Formula 1 and a pharmaceutically acceptable salt thereof:

wherein

R 1 is H or C 1 -C 10 alkyl; and

R 2 is H or C 1 -C 10 alkyl.

2. A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.

3. A compound of claim 1 , wherein

R 1 is H or CH 3 ; and

R 2 is H or CH 3 .

4. A pharmaceutical composition comprising the compound of claim 3 and a pharmaceutically acceptable carrier.

Assignments (3)
MERGER Recorded Mar 22, 2012
From: FCB-PHARMICELL CO., LTD.
To: FCB TWELVE CO., LTD.
Reel/Frame 027909/0665 →
CHANGE OF NAME Recorded Mar 22, 2012
From: FCB TWELVE CO., LTD.
To: PHARMICELL CO., LTD.
Reel/Frame 027909/0779 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 22, 2005
From: LEE, GWANG; AHN, YOUNG HWAN; PARK, KI HO; JUN, HONG KI
To: FCB-PHARMICELL CO., LTD.
Reel/Frame 017860/0064 →
Priority Claims (1)
KR 1020030019238 · Mar 27, 2003 · national
Continuity (1)
Related Publication 20060211681A1 · Sep 21, 2006